» Articles » PMID: 17100877

Activation, Coactivation, and Costimulation of Resting Human Natural Killer Cells

Overview
Journal Immunol Rev
Date 2006 Nov 15
PMID 17100877
Citations 288
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer (NK) cells possess potent perforin- and interferon-gamma-dependent effector functions that are tightly regulated. Inhibitory receptors for major histocompatibility complex class I display variegated expression among NK cells, which confers specificity to individual NK cells. Specificity is also provided by engagement of an array of NK cell activation receptors. Target cells may express ligands for a multitude of activation receptors, many of which signal through different pathways. How inhibitory receptors intersect different signaling cascades is not fully understood. This review focuses on advances in understanding how activation receptors cooperate to induce cytotoxicity in resting NK cells. The role of activating receptors in determining specificity and providing redundancy of target cell recognition is discussed. Using Drosophila insect cells as targets, we have examined the contribution of individual receptors. Interestingly, the strength of activation is not determined simply by additive effects of parallel activation pathways. Combinations of signals from different receptors can have different outcomes: synergy, no enhancement over individual signals, or additive effects. Cytotoxicity requires combined signals for granule polarization and degranulation. The integrin leukocyte function-associated antigen-1 contributes a signal for polarization but not for degranulation. Conversely, CD16 alone or in synergistic combinations, such as NKG2D and 2B4, signals for phospholipase-C-gamma- and phosphatidylinositol-3-kinase-dependent degranulation.

Citing Articles

PRMT5 highly expressed on CD16 + CD56- natural killer cells is correlated with NK cells exhaustion in colorectal cancer mesenchyme.

Nie Z, Chang J, Yang Z, Zeng K, Liu Y, Tu Q Cancer Immunol Immunother. 2025; 74(4):139.

PMID: 40056169 PMC: 11890482. DOI: 10.1007/s00262-025-03981-w.


Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma.

Huang Y, Liao H, Luo J, Wei H, Li A, Lu Y Front Oncol. 2025; 14:1502270.

PMID: 39906665 PMC: 11790413. DOI: 10.3389/fonc.2024.1502270.


Development of BCMA-Targeted Bispecific Natural Killer Cell Engagers for Multiple Myeloma Treatment.

Zhang M, Loh H, Goh Fang S, Yang Y, Lam K, Xu S Antibodies (Basel). 2024; 13(4).

PMID: 39727480 PMC: 11672634. DOI: 10.3390/antib13040097.


From tumor microenvironment to emerging biomarkers: the reshaping of the esophageal squamous cell carcinoma tumor microenvironment by neoadjuvant chemotherapy combined with immunotherapy.

Qiu Z, Li Z, Liu X, Zhang R, Li Y, Gao C Front Immunol. 2024; 15:1478922.

PMID: 39703499 PMC: 11655454. DOI: 10.3389/fimmu.2024.1478922.


A biomathematical model of SARS-CoV-2 in Syrian hamsters.

Schirm S, Nouailles G, Kirsten H, Trimpert J, Wyler E, Teixeira Alves L Sci Rep. 2024; 14(1):30541.

PMID: 39695178 PMC: 11655638. DOI: 10.1038/s41598-024-80498-9.


References
1.
Franco S, Rodgers M, Perrin B, Han J, Bennin D, Critchley D . Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat Cell Biol. 2004; 6(10):977-83. DOI: 10.1038/ncb1175. View

2.
Lee K, McNerney M, Stepp S, Mathew P, Schatzle J, Bennett M . 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J Exp Med. 2004; 199(9):1245-54. PMC: 2211902. DOI: 10.1084/jem.20031989. View

3.
Kumaresan P, Lai W, Chuang S, Bennett M, Mathew P . CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function. Mol Immunol. 2002; 39(1-2):1-8. DOI: 10.1016/s0161-5890(02)00094-9. View

4.
Tassi I, Colonna M . The cytotoxicity receptor CRACC (CS-1) recruits EAT-2 and activates the PI3K and phospholipase Cgamma signaling pathways in human NK cells. J Immunol. 2005; 175(12):7996-8002. DOI: 10.4049/jimmunol.175.12.7996. View

5.
Takeuchi T, Nakagawa T, Ikemoto T, Sasaki M, Makino S, Shimizu A . A novel mutation in the FcgammaRIIIA gene (CD16) results in active natural killer cells lacking CD16. Autoimmunity. 2000; 31(4):265-71. DOI: 10.3109/08916939908994072. View